ASIA IMMUNOTHERAPY is a medical group specializing in cancer immune cell therapy. We work in close collaboration with Japan’s leading immunotherapy authority, Dr. Yoichi Kato, to offer cutting-edge, personalized treatments—including options for late-stage patients.
Immune cell therapy represents a cutting-edge approach that leverages a patient’s own immune cells to identify and eradicate abnormal cells. Because immune cells can circulate throughout the body—including the lymphatic system, bones, and brain—this therapy is well-suited for a wide range of solid tumors, even those at advanced or metastatic stages.
At our treatment center in Japan, the Shin-Yokohama Kato Clinic, we offer patient-specific immune cell therapy plans under the leadership of Dr. Yoichi Kato—one of Japan’s foremost experts in the field. Each step of the therapeutic journey is supported by our dedicated team of professionals, ensuring a comprehensive and well-coordinated treatment experience.
With over two decades of clinical expertise and more than 2,000 documented immune cell therapy cases, Dr. Kato stands among Japan’s most seasoned practitioners. His approach has been effective for 68% of late-stage patients, with 8% achieving complete remission (CR).
Located at Room 812, 8/F, HK Pacific Centre, Tsim Sha Tsui, provides specialized consultations on immune cell therapy. We will facilitate online consultations with Dr. Kato, guiding patients in planning and streamlining their treatment in Japan.
We dedicate ourselves to employing the world’s most advanced immune cell therapy techniques, backed by a top-tier team with extensive experience. By addressing cancer at its root, we offer individualized, precision treatments that safeguard every patient’s health and foster enduring hope.
An advanced treatment approach that leverages a patient’s own immune cells to seek out and destroy cancer cells.
Through dendritic cell therapy, the body’s immune system can be recalibrated to its “healthy baseline,” enabling it to quickly identify and target cancer cells. This breakthrough paves the way for a safer, more effective, and longer-lasting strategy against cancer. It brings unprecedented hope to countless patients.
Through LAK therapy, patients can rapidly strengthen their immune response, effectively targeting and suppressing cancer cells. Additionally, when combined with other treatments—such as dendritic cell (DC) vaccine therapy—or conventional methods, LAK therapy can yield even more comprehensive, synergistic benefits in the battle against cancer.
NK therapy delivers a robust immune offensive against severe diseases and cancer cells. When combined with other treatments—such as LAK therapy, dendritic cell (DC) vaccines, or conventional strategies—it often demonstrates synergistic benefits, providing patients with a proactive route back to health.
Compared to conventional treatments like chemotherapy and radiotherapy, immunotherapy generally has fewer side effects and allows patients to maintain a higher quality of life.
Overall, immunotherapy side effects tend to be less severe than those seen in chemotherapy or radiotherapy, offering new hope to patients in their battle against serious diseases. By working closely with experienced physicians and maintaining healthy habits and a positive mindset, patients can minimize side effects and improve their odds of overcoming illness.
Compared to conventional treatments (chemotherapy, radiotherapy), immunotherapy costs are typically higher, driven by factors like research and development, drug procurement, specialized lab techniques, and a skilled medical team. However, as the technology matures, some treatments and medications are increasingly covered by insurance or governmental support, gradually reducing their out-of-pocket expense.
Lecturer in Radiology, St. Marianna University School of Medicine | Vice President, Yokohama Surgical Association. Specialist: Medical Oncology & Gastroenterology
Read Detail
